MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$490,002K
Marketable securities,
current
$146,239K
Prepayments and other
receivables
$38,138K
Restricted cash
$1,321K
Total current assets
$675,700K
Marketable securities, net
of current portion
$92,609K
Intangible assets
$407K
Property, plant and
equipment, net
$383K
Operating right of use
asset
$185K
Total assets
$769,284K
Total liabilities and
shareholders' equity
$769,284K
Total shareholders'
equity
$683,431K
Total liabilities
$85,853K
Accumulated loss
-$762,390K
Additional paid-in capital
$1,426,750K
Total current
liabilities
$85,787K
Lease liability, net
of current portion
$66K
Ordinary shares
$14,278K
Accumulated other
comprehensive income
$4,793K
Derivative warrant
liabilities
$57,272K
Accrued expenses and
other current...
$15,422K
Accounts payable
$8,970K
Deferred revenue,
current
$3,987K
Lease liability,
current
$136K
Back
Back
Balance Sheet
source: myfinsight.com
NewAmsterdam Pharma Co N.V. (NAMS)
NewAmsterdam Pharma Co N.V. (NAMS)